ArticleOncotarget2018

A novel, dual pan-PIM/FLT3 inhibitor SEL24 exhibits broad therapeutic potential in acute myeloid leukemia.

Wojciech Czardybon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.